Nav: Home

An enzyme in immune cells plays essential role in host defense against tuberculosis

November 13, 2018

BIRMINGHAM, Ala. - Using freshly resected lung tissue from 21 patients and two distinct mouse models, tuberculosis researchers at the University of Alabama at Birmingham and the Africa Health Research Institute, or AHRI, have identified a protein that plays an essential role in host defense against this deadly disease.

The research is led by Andries "Adrie" Steyn, Ph.D., a UAB professor of microbiology who maintains labs at both UAB and the AHRI, in Durban, South Africa. Due to very high rates of tuberculosis, or TB, in South Africa, infected human lung tissue is readily available from nearby hospitals, as patients undergo surgery as a last hope for recovery.

Direct study of microanatomic niches in the fresh lung tissue -- including healthy and severely diseased areas -- then can reveal the differences in immune responses and cell activity in these distinct regions. Steyn and his research team say this unique approach will aid in identifying potential host factors that could be therapeutically targeted to limit the extensive tissue damage associated with chronic pulmonary TB disease. This dangerous lung tissue, including lungs infected with multi-drug-resistant or extensively drug-resistant TB bacteria, is carefully handled in an advanced biosafety lab at the AHRI because as few as one to three TB bacteria in an aerosol droplet can cause infection. TB infections by the bacterium Mycobacterium tuberculosis, or Mtb, kill about 1.3 million people a year.

Steyn and colleagues were able to separate different types of cells found in distinct niches of human freshly resected TB lungs and characterize those cells for production of the protein heme oxygenase-1. Heme oxygenase-1, or HO-1, is an enzyme that protects cells from harmful reactive oxygen or nitrogen intermediates; HO-1 also is able to control inflammatory responses.

The researchers found that HO-1 in human TB lungs was expressed primarily by myeloid immune cells, including neutrophils and macrophages, and that HO-1 levels in these cells were directly proportional to protection against TB pathophysiology.

Specifically, there was a greater percentage of HO-1-producing neutrophils and macrophages in uninfected areas of the lung than in diseased areas, and those cells in uninfected areas produced more HO-1 than the cells in diseased areas. As a consequence, the lack of HO-1 protection in diseased areas allowed myeloid cell-production of destructive reactive oxygen and nitrogen species. What makes these findings clinically relevant is that HO-1 is essential in humans but not in mice, which points to the importance of examining human TB lung tissue to complement animal models for TB.

"To the best of my knowledge, this extensive analysis of freshly resected human TB lung tissue is the first of its kind, as these lungs are scarce," Steyn said.

This finding in humans was supported by two HO-1 deficient mouse models that showed HO-1 is necessary to control myeloid cell infiltration and inflammation to protect against TB progression. One mouse model was a global knockout of the HO-1 gene; the other model was an HO-1 knockout in myeloid cells only. In both models, knockout mice had more susceptibility to Mtb infection -- the knockout mice died sooner and had higher loads of Mtb in their lungs and spleens. The knockout mice also had increased infiltration of immune cells and levels of cytokines, the cell-signaling proteins that regulate or stimulate immune responses.

Overall, the findings from human lungs and the mouse models showed that expression of HO-1, especially within myeloid cells, appears to be essential for host defense against Mtb disease progression. For human TB patients, Steyn says, the research suggests that finding a way to upregulate HO-1 activity might limit immunopathology during active TB disease.

This research was published Nov. 13 in the journal Cell Reports, and it is also featured on the front cover of the journal.

Two labs, a world apart

Steyn is a professor and primary faculty at UAB Department of Microbiology and maintains a research laboratory at UAB. He is also a full-time investigator at AHRI and lives in Durban, South Africa. He visits UAB at least six times a year.

Steyn is responsible for creating a program where students from UAB Graduate School and School of Medicine get a unique opportunity to visit and conduct research at AHRI as part of research training internships. "Once you go to remote areas in Africa and see the devastation of the disease," Steyn has said, "it just changes you. It makes a difference."

Working at AHRI gives students, especially those in the medical training program, an excellent opportunity to work in a state-of-the-art research facility located in a country with one of the highest disease burdens in the world. Seven UAB Ph.D. and M.D./Ph.D. students have done research in Steyn's lab in Durban as part of the annual UAB-AHRI International Summer Research Program.

Steyn's Cell Reports work follows an earlier study also using human TB lung tissue. That study, published last May in Frontiers in Immunology by Steyn and colleagues, examined the distribution of iron in diseased TB lungs. Iron is an essential factor for the growth and virulence of Mtb, but little was known about how the host controls iron availability during infection.

Steyn and colleagues found an essential role for the ferritin H iron-storage protein in the control of TB, which is directly linked to HO-1. The researchers found that a mouse model that had a knockout of the ferritin heavy chain gene in myeloid cells was more susceptible to TB, as shown by increased numbers of Mtb in organs, more spread of Mtb beyond the lungs and decreased survival. Notably, reduced levels of iron were found in human TB lungs.
The Cell Reports paper, "Microanatomic distribution of myeloid heme oxygenase-1 protects against free radical-mediated immunopathology in human pulmonary tuberculosis," was the result of team work led by first author Krishna C. Chinta. The research also included other members of Steyn's team: Vikram Saini, Joel N. Glasgow and Vineel P. Reddy at the UAB Department of Microbiology and Md. Aejazur Rahman, Kievershen Nargan and Gordon Wells at AHRI. Vikram is now at the All India Institute of Medical Sciences, New Delhi, India.

In Alabama, collaborations with Anupam Agarwal, UAB executive vice dean and director of the UAB Division of Nephrology, and James George, professor in the Division of Cardiothoracic Surgery, UAB Department of Surgery, were crucial for the project, says Steyn. Agarwal lab members Jeremie M. Lever and Amie Traylor were also involved in the study. Also, contributions by co-authors Pratistadevi K. Ramdial and Rajhmun Madansein, Inkosi Albert Luthuli Central Hospital and University of KwaZulu-Natal, Durban, South Africa, were significant.

Along with above-mentioned researchers, co-authors in the Cell Reports paper are Ryan M. Wells, UAB Department of Microbiology (currently at University of Minnesota); Shepherd Nhamoyebonde and Alasdair Leslie, AHRI, Durban, South Africa; Gene P. Siegal, UAB Department of Pathology; and Veena B. Antony and Jessy Deshane, Division of Pulmonary, Allergy and Critical Care Medicine, UAB Department of Medicine.

Support for this work came from National Institutes of Health grants AI111940, AI127182 and DK59600; the Bill and Melinda Gates Foundation award OPP1130017; and the South African Medical Research Council. Support also came from the UAB Center for AIDS Research and the UAB Center for Free Radical Biology.

At UAB, Agarwal holds the Marie S. Ingalls Endowed Chair in Nephrology Leadership, George holds the Cardiovascular Surgical Research Chair, and Siegal holds the Robert W. Mowry Endowed Professorship in Pathology.

University of Alabama at Birmingham

Related Tuberculosis Articles:

Blocking the iron transport could stop tuberculosis
The bacteria that cause tuberculosis need iron to survive. Researchers at the University of Zurich have now solved the first detailed structure of the transport protein responsible for the iron supply.
Tuberculosis: New insights into the pathogen
Researchers at the University of Würzburg and the Spanish Cancer Research Centre have gained new insights into the pathogen that causes tuberculosis.
Unmasking the hidden burden of tuberculosis in Mozambique
The real burden of tuberculosis is probably higher than estimated, according to a study on samples from autopsies performed in a Mozambican hospital.
HIV/tuberculosis co-infection: Tunneling towards better diagnosis
1.2 million people in the world are co-infected by the bacteria which causes tuberculosis and AIDS.
Reducing the burden of tuberculosis treatment
A research team led by MIT has developed a device that can lodge in the stomach and deliver antibiotics to treat tuberculosis, which they hope will make it easier to cure more patients and reduce health care costs.
Tuberculosis: Commandeering a bacterial 'suicide' mechanism
The bacteria responsible for tuberculosis can be killed by a toxin they produce unless it is neutralized by an antidote protein.
A copper bullet for tuberculosis
Tuberculosis is a sneaky disease, and the number one cause of death from infectious disease worldwide.
How damaging immune cells develop during tuberculosis
Insights into how harmful white blood cells form during tuberculosis infection point to novel targets for pharmacological interventions, according to a study published in the open-access journal PLOS Pathogens by Valentina Guerrini and Maria Laura Gennaro of Rutgers New Jersey Medical School, and colleagues.
How many people die from tuberculosis every year?
The estimates for global tuberculosis deaths by the World Health Organisation (WHO) and the Institute for Health Metrics and Evaluation (IHME) differ considerably for a dozen countries, according to a study led by ISGlobal.
Beyond killing tuberculosis
Historically, our view of host defense against infection was that we must eliminate pathogens to eradicate disease.
More Tuberculosis News and Tuberculosis Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at